Health Canada Approves Pfizer’s Antiviral Pill for COVID-19
Health Canada has approved Pfizer’s antiviral pill for COVID-19 for adults with mild or moderate cases of the virus who are also at high risk of becoming more seriously ill. It is not authorized for teens or patients already hospitalized for COVID-19.
Clinical trials show the drug is almost 90% effective at preventing serious illness in higher-risk patients who received it within the first five days of being infected.
Its viewed as a game changer in the pandemic that could significantly reduce hospitalizations, death and the impact of the virus on the health care system.